| Current Price | $7.18 | Mkt Cap | $786.0M |
|---|---|---|---|
| Open | $7.49 | P/E Ratio | 0.00 |
| Prev. Close | $7.18 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.95 - $7.74 | Volume | 9,183,471 |
| 52-Wk Range | $0.40 - $17.49 | Avg. Daily Vol. | 8,359,365 |
| Current Price | $7.18 | Mkt Cap | $786.0M |
|---|---|---|---|
| Open | $7.49 | P/E Ratio | 0.00 |
| Prev. Close | $7.18 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.95 - $7.74 | Volume | 9,183,471 |
| 52-Wk Range | $0.40 - $17.49 | Avg. Daily Vol. | 8,359,365 |
The best Bull and Bear pitches based on recency and number of recommendations.
it's doubled now vs 3 weeks ago, and when they announce the COVID-19 vaccine will go even higher
My company just gave the janitor the Employee of the Month Award in a big ceremony that he spent hours cleaning up afterwards.
Read the most recent pitches from players about VXRT.
Recs
RebelHamster
(94.21)
Submitted: 12/29/2020 11:49:11 AM :
Start Price:
$5.84
NASDAQ:VXRT Score:
-22.08
Valuation
Recs
TMFjbonefish
(55.03)
Submitted: 12/16/2020 6:51:06 PM :
Start Price:
$7.60
NASDAQ:VXRT Score:
-6.54
It's a gamble but the upside of a tablet based vaccine, especially for the seasonal flu, is immense. I think the upside outweighs the potential downside.
Recs
TMFjimhalley
(69.10)
Submitted: 12/14/2020 9:47:21 PM :
Start Price:
$8.02
NASDAQ:VXRT Score:
+12.69
The company's valuation is too high considering that its oral COVID-19 vaccine candidate hasn't been approved. The clinical-stage biotech company is still looking for a blockbuster therapy and considering its lack of earnings, doesn't rate its current share price.
Find the members with the highest scoring picks in VXRT.
portefeuille (98.73) Score: +869.36
The Score Leader is the player with the highest score across all their picks in VXRT.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| portefeuille | 98.73 | 4/29/2019 |
|
5Y | $0.72 | +897.36% | +28.00% | +869.36 | 0 Comment | |
| odocoileus | 83.38 | 4/1/2020 |
|
5Y | $1.71 | +319.88% | +50.91% | +268.98 | 1 Comment | |
| PLAZMASTOX | 29.57 | 4/17/2020 |
|
1Y | $1.95 | +269.00% | +31.65% | +237.35 | 0 Comment | |
| ngocthe2001 | 66.99 | 6/3/2020 |
|
5Y | $2.91 | +146.74% | +21.11% | +125.62 | 0 Comment | |
| northcutt0 | < 20 | 4/27/2020 |
|
5Y | $3.25 | +120.92% | +31.75% | +89.18 | 0 Comment | |
| alvinpall | 88.18 |
|
|
1Y | $3.36 | +113.69% | +28.90% | +84.79 | 1 Comment | |
| Almostperfect1 | 63.33 | 7/13/2020 |
|
5Y | $12.08 | -40.56% | +19.36% | +59.92 | 0 Comment | |
| NorteClub | 30.15 | 7/29/2020 |
|
5Y | $11.30 | -36.46% | +16.63% | +53.09 | 0 Comment | |
| ttkam20 | 97.10 | 9/4/2020 |
|
5Y | $4.81 | +49.27% | +9.19% | +40.09 | 0 Comment | |
| farhangp | 71.19 | 11/16/2020 |
|
5Y | $5.24 | +37.02% | +4.03% | +33.00 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
